[go: up one dir, main page]

DK97784D0 - Dna-segment - Google Patents

Dna-segment

Info

Publication number
DK97784D0
DK97784D0 DK0977/84A DK97784A DK97784D0 DK 97784 D0 DK97784 D0 DK 97784D0 DK 0977/84 A DK0977/84 A DK 0977/84A DK 97784 A DK97784 A DK 97784A DK 97784 D0 DK97784 D0 DK 97784D0
Authority
DK
Denmark
Prior art keywords
gene
segment
dna
vector
yeast
Prior art date
Application number
DK0977/84A
Other languages
English (en)
Other versions
DK97784A (da
Inventor
David Botstein
Ronald Wayne Davis
Gerald Ralph Fink
Rigby Alison Taunton
Robert Gentry Knowlton
Jen-I Mao
Donald Taylor Moir
Christopher Godfrey Goff
Original Assignee
Collaborative Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23869556&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK97784(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collaborative Res Inc filed Critical Collaborative Res Inc
Publication of DK97784D0 publication Critical patent/DK97784D0/da
Publication of DK97784A publication Critical patent/DK97784A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
  • Peptides Or Proteins (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Road Signs Or Road Markings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK97784A 1983-02-28 1984-02-24 Dna-segment DK97784A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/470,911 US4661454A (en) 1983-02-28 1983-02-28 GAL1 yeast promoter linked to non galactokinase gene

Publications (2)

Publication Number Publication Date
DK97784D0 true DK97784D0 (da) 1984-02-24
DK97784A DK97784A (da) 1984-08-29

Family

ID=23869556

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97784A DK97784A (da) 1983-02-28 1984-02-24 Dna-segment

Country Status (8)

Country Link
US (1) US4661454A (da)
EP (1) EP0123811B1 (da)
JP (1) JPS6058077A (da)
AT (1) ATE64416T1 (da)
CA (1) CA1283373C (da)
DE (1) DE3484689D1 (da)
DK (1) DK97784A (da)
GB (1) GB2137208B (da)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128743A3 (en) * 1983-06-07 1985-12-27 Genex Corporation Expression of foreign genes in yeast
EP0132309A3 (en) * 1983-06-27 1985-12-27 The Board Of Trustees Of The Leland Stanford Junior University Novel regulatable eukaryotic promoter element
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US4990446A (en) * 1984-12-06 1991-02-05 Labofina, S.A. Promoters for the expression of foreign genes in yeast, plasmids comprising them, and use thereof for the production of polypeptides
US4861868A (en) * 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
US5037806A (en) * 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
JP2615027B2 (ja) * 1985-04-08 1997-05-28 アムジェン インコーポレイテッド 外来遺伝子の転写を制御するための方法及びハイブリッドプロモーター
DE3689020T2 (de) * 1985-08-02 1994-04-07 Merck & Co Inc Fermentationsausbeute an exprimiertem Protein.
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
US5002876A (en) * 1986-09-22 1991-03-26 Phillips Petroleum Company Yeast production of human tumor necrosis factor
US5013652A (en) * 1986-10-14 1991-05-07 Genex Corporation Composite yeast vectors
US5882884A (en) * 1987-06-19 1999-03-16 Lucky Biotech Corporation Expression of proteinaceous sweeteners in yeast
US5487990A (en) * 1988-07-01 1996-01-30 The General Hospital Corporation Glucose-regulated promoter of yeast acetyl-CoA hydrolase
US5057419A (en) * 1988-09-22 1991-10-15 Rutgers University Genetically engineered plasmid and organisms for the production of specialized oils
US5187079A (en) * 1988-12-21 1993-02-16 The Research Foundation Of State University Of New York Glucose-repressible gene for the regulated expression of proteins and expression vector therefor
WO1991014780A1 (en) * 1990-03-21 1991-10-03 Board Of Regents, The University Of Texas System Yeast expression vectors
JP3348406B2 (ja) 1990-09-13 2002-11-20 デューク ユニバーシティー 酵母におけるｇタンパク質結合受容体の発現
JPH04287683A (ja) * 1991-03-14 1992-10-13 Ajinomoto Co Inc 酵母変異株およびそれを利用するペプチドまたは蛋白質　　　　　　　　　　　等の製造方法
GB9226065D0 (en) * 1992-12-14 1993-02-10 Ici Plc Peptides
DE4303744A1 (de) * 1993-02-09 1994-08-11 Univ Autonoma De Nuevo Leon Mo Hundewachstumshormon
DE19534120A1 (de) 1995-09-14 1997-03-20 Hoechst Ag Verwendung von Cytohesin-PH-Peptiden zur Beeinflußung der Adhäsionsfähigkeit von Integrinen
WO1997024457A1 (en) 1995-12-29 1997-07-10 Guilford Pharmaceuticals Inc. Method and kit for detection of multiple protein interactions
US5886151A (en) * 1996-05-03 1999-03-23 Regents Of The University Of Minnesota Candida albicans integrin-like protein
KR100611063B1 (ko) 1996-10-16 2006-08-09 지모제넥틱스, 인코포레이티드 섬유아세포 성장인자 상동체
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
GB9726897D0 (en) * 1997-12-20 1998-02-18 Zeneca Ltd Process
EA201001190A1 (ru) 1998-09-23 2011-04-29 Займодженетикс, Инк. Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
ES2312223T3 (es) 1998-12-07 2009-02-16 Zymogenetics, Inc. Zvegf3 homologo de factor de crecimiento.
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
DK1642973T3 (da) 1999-01-07 2009-11-02 Zymogenetics Inc Terapeutisk anvendelser af BR43X2-oplöselige receptorer
BR0008772B1 (pt) 1999-03-09 2011-11-01 vetor de expressão, célula bacteriana ou fúngica cultivada, processos para expandir in vitro células hematopoiéticas e progenitores de células hematopoiéticas, e para detectar a presença de rna de ligando zalfa11 e de ligando zalfa 11 in vitro em uma amostra biológica.
DE60034564T2 (de) 1999-07-07 2007-12-27 Zymogenetics, Inc., Seattle Menschlicher cytokinrezeptor
ATE459716T1 (de) 1999-12-23 2010-03-15 Zymogenetics Inc Zytokin zcyt018
ATE473280T1 (de) 2000-05-11 2010-07-15 Zymogenetics Inc Zsig33-ähnliche peptide
EP2258725A3 (en) 2000-06-26 2014-09-17 ZymoGenetics, L.L.C. Cytokine receptor zcytor17
CA2413258C (en) 2000-06-30 2012-01-03 Zymogenetics, Inc. Interferon-like protein zcyto21
EP1736545A3 (en) 2000-08-08 2007-03-28 ZymoGenetics, Inc. Soluble zcytor 11 cytokine receptors
CA2433534A1 (en) * 2000-12-28 2002-07-11 Toyota Jidosha Kabushiki Kaisha Process for producing prenyl alcohol
AU2002238052A1 (en) 2001-02-20 2002-09-04 Zymogenetics, Inc. Antibodies that bind both bcma and taci
MXPA03010687A (es) 2001-05-24 2004-07-01 Zymogentetics Inc Proteinas de fusion de taci-inmunoglobulina.
EP2130919A1 (en) 2001-11-05 2009-12-09 ZymoGenetics, Inc. IL-21 antagonists
ATE547430T1 (de) 2002-01-18 2012-03-15 Zymogenetics Inc Multimere des cytokinrezeptors zcytor17
DE60333963D1 (de) 2002-01-18 2010-10-07 Zymogenetics Inc Zytokin Ligand zur Behandlung von Asthma und Atemwegsüberreaktivität
RU2004133765A (ru) 2002-04-19 2005-06-27 ЗАЙМОДЖЕНЕТИКС Инк. (US) Рецептор цитокина
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US20080050808A1 (en) * 2002-10-09 2008-02-28 Reed Thomas D DNA modular cloning vector plasmids and methods for their use
US7785871B2 (en) * 2002-10-09 2010-08-31 Intrexon Corporation DNA cloning vector plasmids and methods for their use
CA2534907C (en) 2003-08-07 2014-04-29 Zymogenetics, Inc. Homogeneous preparations of il-28 and il-29
CN1283792C (zh) * 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
US7381794B2 (en) 2004-03-08 2008-06-03 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
AU2005248371B2 (en) * 2004-05-18 2011-12-15 Intrexon Corporation Methods for dynamic vector assembly of DNA cloning vector plasmids
AU2005266892B2 (en) 2004-07-29 2011-03-03 Bristol-Myers Squibb Company Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
EP1781784A2 (en) 2004-08-02 2007-05-09 BASF Plant Science GmbH Method for isolation of transcription termination sequences
WO2006086396A2 (en) 2005-02-08 2006-08-17 Zymogenetics, Inc. Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
EP3683230A1 (en) 2005-05-12 2020-07-22 ZymoGenetics, Inc. Compositions and methods for modulating immune responses
JP5118037B2 (ja) 2005-08-09 2013-01-16 ザイモジェネティクス， インコーポレイテッド Ｔａｃｉ融合分子を用いた異常細胞増殖の処置及び予防のための方法
AU2006278229B2 (en) * 2005-08-09 2011-10-27 Ares Trading S.A. Methods for treating B-cell malignancies using TACI-Ig fusion molecule
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
UA98462C2 (ru) * 2006-05-15 2012-05-25 Арес Трейдинг С.А. Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig
US20100240597A1 (en) 2007-06-15 2010-09-23 Arkansas State University Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
US12529164B2 (en) 2007-09-14 2026-01-20 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
WO2009036379A2 (en) 2007-09-14 2009-03-19 Adimab, Inc. Rationally designed, synthetic antibody libraries and uses therefor
CA2706550C (en) 2007-11-21 2021-12-14 Roskilde Universitet Polypeptides comprising an ice-binding activity
EP2231702A1 (en) * 2007-12-21 2010-09-29 Ifxa A/s Protease inhibitor
NZ600205A (en) * 2008-01-25 2013-12-20 Univ Aarhus Selective exosite inhibition of papp-a activity against igfbp-4
ES2456296T3 (es) 2008-03-27 2014-04-21 Zymogenetics, Inc. Composiciones y procedimientos para inhibir PDGFR beta y VEGF-A
US8658766B2 (en) 2008-06-27 2014-02-25 Zymogenetics, Inc. Soluble hybrid Fcγ receptors and related methods
WO2011156356A1 (en) 2010-06-09 2011-12-15 Zymogenetics, Inc. Dimeric vstm3 fusion proteins and related compositions and methods
CA3156904A1 (en) 2012-02-01 2013-08-08 Synthetic Genomics, Inc. Materials and methods for the synthesis of error-minimized nucleic acid molecules
WO2014202089A2 (en) 2013-06-18 2014-12-24 Roskilde Universitet Variants of anti-freeze polypeptides
CN106318943B (zh) * 2015-06-29 2019-03-05 中国科学院大连化学物理研究所 半乳糖激酶启动子和终止子及其应用
CN106318942B (zh) * 2015-06-29 2018-12-25 中国科学院大连化学物理研究所 一种半乳糖激酶启动子和终止子及其应用
KR102440820B1 (ko) 2015-09-08 2022-09-05 테리피온, 인크. ApoA-1 융합 폴리펩티드 및 관련 조성물 및 방법
US11352426B2 (en) 2015-09-21 2022-06-07 Aptevo Research And Development Llc CD3 binding polypeptides
WO2018136163A2 (en) 2016-12-09 2018-07-26 Theripion, Inc. Tandem apoa-1 fusion polypeptides
BR112020001180A2 (pt) 2017-07-20 2020-09-08 Aptevo Research And Development Llc proteínas de ligação a antígenos que se ligam a 5t4 e 4-1bb e composições e métodos relacionados
JP7087107B2 (ja) 2017-12-20 2022-06-20 ハーバー・バイオメド・（シャンハイ）・カンパニー・リミテッド Ｃｔｌａ－４に結合する抗体およびその使用
ES3039238T3 (en) 2017-12-27 2025-10-20 Imunami Laboratories Pte Ltd Recombinant polypeptides and methods of use thereof
US10150801B1 (en) 2017-12-27 2018-12-11 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
WO2021040610A1 (en) 2019-08-26 2021-03-04 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
US10675332B1 (en) 2019-08-26 2020-06-09 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
CN116568317A (zh) 2020-06-22 2023-08-08 免疫实验室私人有限公司 用于癌症治疗的重组多肽和组合
EP4294916A2 (en) 2021-02-19 2023-12-27 Theripion, Inc. Dnase fusion polypeptides and related compositions and methods
KR20250133692A (ko) 2023-01-06 2025-09-08 압테보 리서치 앤드 디벨롭먼트 엘엘씨 이중특이성 pd-l1 및 cd40 결합 분자 그리고 이의 용도
WO2024259220A1 (en) 2023-06-15 2024-12-19 Theripion, Inc. Pon3 and evolved pon1 fusion polypeptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
US4666847A (en) * 1981-01-16 1987-05-19 Collaborative Research, Inc. Recombinant DNA means and method
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
EP0128743A3 (en) * 1983-06-07 1985-12-27 Genex Corporation Expression of foreign genes in yeast
EP0132309A3 (en) * 1983-06-27 1985-12-27 The Board Of Trustees Of The Leland Stanford Junior University Novel regulatable eukaryotic promoter element

Also Published As

Publication number Publication date
EP0123811B1 (en) 1991-06-12
DE3484689D1 (de) 1991-07-18
GB2137208B (en) 1987-05-13
GB8405129D0 (en) 1984-04-04
EP0123811A2 (en) 1984-11-07
US4661454A (en) 1987-04-28
EP0123811A3 (en) 1986-03-26
GB2137208A (en) 1984-10-03
ATE64416T1 (de) 1991-06-15
DK97784A (da) 1984-08-29
JPS6058077A (ja) 1985-04-04
CA1283373C (en) 1991-04-23

Similar Documents

Publication Publication Date Title
DK97784D0 (da) Dna-segment
DK0378382T3 (da) Rekombinant DNA-fremgangsmåde og værtsceller
ATE103333T1 (de) Hohe proteinsyntheserate in hefe.
DK101385A (da) Molekylaer kloning og ekspression i industrielle mikroorganismearter
ATE27000T1 (de) Expression von polypeptiden in hefen.
KR880014110A (ko) 인체 프로아포지방단백질 a-i의 발현
IL71906A (en) Method for producing a baculovirus vector capable of producing a selected non-fused recombinant protein or capable of being utilized as a transfer vector;a recombinant baculovirus expression vector capable of expressing under the control of a baculovirus polyhedrin promoter a selected non-fused protein in a host insect cell;a recombinant transfer vector utilizing a baculovirus polyhedrin promoter and flanking sequences for introducing a selected gene into a baculovirus genome,or for insertion of a selected gene for a genetic manipulation of a baculovirus;and a method for the synthesis of a selected non-fused protein in a host insect cell using the expression vector
PT83968A (de) Verfahren zur verbesserung des expression von eukaryontenprotein
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
KR940002352A (ko) 디(d)-아미노산 옥시다제 생산성 형질전환체
Yamaguchi et al. Chick embryo DNA polymerase alpha. Polypeptide components and their microheterogeneity.
CA2037677A1 (en) Process for production of exogenous gene or its product in plant cells
DE59109072D1 (de) Klonierung der N-Methylhydantoinase
DE3882455D1 (de) Verfahren zur herstellung von proteinen in loeslicher form.
Lübke et al. Analysis and optimization of recombinant protein production in Escherichia coli using the inducible pho A promoter of the E. coli alkaline phosphatase
ATE122097T1 (de) Expressionsvektor und verfahren zur regulierbaren herstellung von proteinen in eukaryonten.
ATA282386A (de) Verfahren zur expression von genen in hefe und dna-fragmente und diese dna-fragmente enthaltende plasmide zur verwendung bei diesem verfahren
EP0194626A3 (en) Method for transformation and direct selection of transformants in eucaryotic cells
ATE107358T1 (de) System der induzierbaren positiven regulation zur verwendung für die herstellung von heterologen proteinen.
Szponarski et al. Identification of 14 kDa auxin‐binding proteins in a tobacco plasma membrane subfraction responsive to auxin
IT1236844B (it) Clonaggio del gene regolabile nmt1 di schizosaccharomyces pombe e impiego delle sequenze di controllo della regolazione della trascrizione di tale gene per l'espressione regolabile di geni eterologhi
DE59008764D1 (de) t-PA-MUTANTE GK1L.
MX9702889A (es) Mejoramiento de un vector de expresion para la produccion de proteinas recombinantes.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment